ESR1 and breast cancer: The interaction of both mechanisms for producing the intermediate E/M gene expression signature, cooperation and the presence of hybrid E/M cells may account for the robustness with which E/M co-expression predicts poor outcome in both ER+ and ER- breast cancer – to our knowledge the first gene expression signature that predicts outcome independent of tumor- subtype in breast cancer (Fig 2).